Although this was a preliminary study, it demonstrated the differential glycosylation pattern between CA125 antigens from normal and cancer origins, and the potential use of a lectin-based assay to discriminate CA125 glycoforms and to complement the total CA125 concentration test, improving its diagnostic performance towards the detection of ovarian cancer. The gene discussed is MUC16; the disease is cancer.